Marques, F. Z., Prestes, P. R., Byars, S. G., Ritchie, S. C., Würtz, P., Patel, S. K., Booth, S. A., Rana, I., Minoda, Y., Berzins, S. P., Curl, C. L., Bell, J. R., Wai, B., Srivastava, P. M., Kangas, A. J., Soininen, P., Ruohonen, S., Kähönen, M., Lehtimäki, T., Raitoharju, E., Havulinna, A., Perola, M., Raitakari, O., Salomaa, V., Ala‐Korpela, M., Kettunen, J., McGlynn, M., Kelly, J., Wlodek, M. E., Lewandowski, P. A., Delbridge, L. M., Burrell, L. M., Inouye, M., Harrap, S. B., & Charchar, F. J. (2017). experimental and Human Evidence for Lipocalin‐2 (Neutrophil Gelatinase‐Associated Lipocalin [NGAL]) in the Development of Cardiac Hypertrophy and Heart Failure. Journal of the American Heart Association, 6(6), n/a. http://access.bl.uk/ark:/81055/vdc_100047553555.0x000008